// App-Quantinova.ai

TCT-292 : Three-year clinical outcome of patients treated with the Nobori biolimus-eluting stent and Xience/Promus cobalt-chromium everolimus-eluting stent for unprotected left main disease

Researchers

Presenter

  • Shoichi Kuramitsu

Principal Investigators

  • Hiroyuki Jinnouchi

  • Takenori Domei

  • Kyohei Yamaji

  • Makoto Hyodo

  • Yoshimitsu Soga

  • Shinichi Shirai

  • Kenji Ando

Medical Centers

  • Kokura memorial hospital, Kitakyusyu, Japan

  • Kokura memorial hospital, Kitakyusyu, Japan

  • Kitakyushu, Japan

  • Department of Cardiology Kokura Memorial Hospital, Kitakyushu, Japan

  • Kokura memorial hospital, Kitakyusyu, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Left main disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved